Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Levitzki

Showing results (181-190 of 244) with videos related to

Pageof 25
Sort By:
Cancer Journal (Sudbury, Mass.)|June 23, 2001
Signal therapy for RAS-induced cancers in combination of AG 879 and PP1, specific inhibitors for ErbB2 and Src family kinases, that block PAK activationH He, Y Hirokawa, E Manser, et al.
Molecular Cell|June 9, 1999
Crystal structure of Hck in complex with a Src family-selective tyrosine kinase inhibitorT Schindler, F Sicheri, A Pico, et al.
Science (New York, N.Y.)|May 27, 1994
Prevention of lipopolysaccharide-induced lethal toxicity by tyrosine kinase inhibitorsA Novogrodsky, A Vanichkin, M Patya, et al.
Experimental Neurology|January 8, 1999
Suppression of experimental autoimmune encephalomyelitis by tyrphostin AG-556T Brenner, E Poradosu, D Soffer, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 20, 1998
Drug resistance of human glioblastoma cells conferred by a tumor-specific mutant epidermal growth factor receptor through modulation of Bcl-XL and caspase-3-like proteasesM Nagane, A Levitzki, A Gazit, et al.
Biochemistry|May 4, 1993
The tyrosine kinase inhibitor tyrphostin blocks the cellular actions of nerve growth factorM Ohmichi, L Pang, V Ribon, et al.
FEBS Letters|March 3, 1986
Adenylate cyclase activity of NIH 3T3 cells morphologically transformed by ras genesA Levitzki, J Rudick, I Pastan, et al.
The Journal of Cell Biology|May 1, 1991
The inhibition of EGF-dependent proliferation of keratinocytes by tyrphostin tyrosine kinase blockersA Dvir, Y Milner, O Chomsky, et al.
Advances in Cyclic Nucleotide and Protein Phosphorylation Research|January 1, 1984
Resolution, reconstitution, and mode of action of the beta-adrenergic receptor-dependent adenylate cyclaseD Feder, H Arad, A Gal, et al.
Cell Motility and the Cytoskeleton|March 8, 2000
Disruption of microtubules in living cells by tyrphostin AG-1714T Volberg, A D Bershadsky, M Elbaum, et al.
Pageof 25

Showing results (181-190 of 244) with videos related to

Sort By:
Pageof 25
Cancer Journal (Sudbury, Mass.)|June 23, 2001
Signal therapy for RAS-induced cancers in combination of AG 879 and PP1, specific inhibitors for ErbB2 and Src family kinases, that block PAK activationH He, Y Hirokawa, E Manser, et al.
Molecular Cell|June 9, 1999
Crystal structure of Hck in complex with a Src family-selective tyrosine kinase inhibitorT Schindler, F Sicheri, A Pico, et al.
Science (New York, N.Y.)|May 27, 1994
Prevention of lipopolysaccharide-induced lethal toxicity by tyrosine kinase inhibitorsA Novogrodsky, A Vanichkin, M Patya, et al.
Experimental Neurology|January 8, 1999
Suppression of experimental autoimmune encephalomyelitis by tyrphostin AG-556T Brenner, E Poradosu, D Soffer, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 20, 1998
Drug resistance of human glioblastoma cells conferred by a tumor-specific mutant epidermal growth factor receptor through modulation of Bcl-XL and caspase-3-like proteasesM Nagane, A Levitzki, A Gazit, et al.
Biochemistry|May 4, 1993
The tyrosine kinase inhibitor tyrphostin blocks the cellular actions of nerve growth factorM Ohmichi, L Pang, V Ribon, et al.
FEBS Letters|March 3, 1986
Adenylate cyclase activity of NIH 3T3 cells morphologically transformed by ras genesA Levitzki, J Rudick, I Pastan, et al.
The Journal of Cell Biology|May 1, 1991
The inhibition of EGF-dependent proliferation of keratinocytes by tyrphostin tyrosine kinase blockersA Dvir, Y Milner, O Chomsky, et al.
Advances in Cyclic Nucleotide and Protein Phosphorylation Research|January 1, 1984
Resolution, reconstitution, and mode of action of the beta-adrenergic receptor-dependent adenylate cyclaseD Feder, H Arad, A Gal, et al.
Cell Motility and the Cytoskeleton|March 8, 2000
Disruption of microtubules in living cells by tyrphostin AG-1714T Volberg, A D Bershadsky, M Elbaum, et al.
Pageof 25